MEHMET KIVRAK | Biology and Life Sciences | Innovative Research Award

Innovative Research Award

MEHMET KIVRAK
Affiliation Recep Tayyip Erdogan University
Country Turkey
Scopus ID 57211715569
Documents 22
Citations 92
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-2405-8552

MEHMET KIVRAK

Recep Tayyip Erdogan University, Turkey

MEHMET KIVRAK is a researcher affiliated with Recep Tayyip Erdogan University whose scholarly work focuses on Biology and Life Sciences with interdisciplinary applications in clinical medicine, women’s health, artificial intelligence-assisted healthcare, and biomarker discovery. His research portfolio demonstrates consistent contributions to observational clinical studies and translational biomedical investigations published in peer-reviewed international journals.[1]

Abstract

This article summarizes the academic profile of MEHMET KIVRAK in relation to the Innovative Research Award. His published work spans clinical medicine, reproductive health, inflammatory biomarkers, cardiovascular risk assessment, and explainable artificial intelligence. The available publication record indicates sustained engagement in evidence-based biomedical research and collaboration across multiple clinical specialties, contributing to improved understanding of disease mechanisms and patient care.[2]

Keywords

Biology and Life Sciences; Clinical Medicine; Biomarkers; Artificial Intelligence; Women’s Health; Cardiovascular Risk; Medical Research.

Introduction

Modern biomedical research increasingly combines clinical observations with computational analysis to improve diagnosis and treatment. MEHMET KIVRAK has participated in investigations involving pregnancy-related disorders, polycystic ovary syndrome, dermatological diseases, and neurodevelopmental conditions. These studies illustrate an interdisciplinary approach integrating laboratory findings with clinical outcomes.[3]

Research Profile

According to the available author metrics, the researcher has produced 22 indexed documents receiving 92 citations with an h-index of 4. The research emphasizes prospective observational studies, biomarker evaluation, clinical epidemiology, and the application of explainable artificial intelligence to healthcare datasets. These activities reflect continued participation in internationally indexed scientific publishing.[1]

Research Contributions

  • Clinical investigations of hypertensive disorders during pregnancy and urinary health.
  • Evaluation of inflammatory biomarkers including IL-39 in polycystic ovary syndrome.
  • Explainable artificial intelligence for cardiovascular risk prediction in psoriasis.
  • Clinical follow-up studies examining ADHD treatment outcomes and emotional regulation.

Publications

  • Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy (2026).
  • Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome (2026).
  • Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence (2026).
  • Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD (2026).
  • Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı (2025).

Research Impact

The publication record demonstrates continuing contributions to clinical medicine and life sciences through peer-reviewed journals. Research outputs support understanding of women’s health, inflammatory mechanisms, predictive analytics, and evidence-based patient management. Citation activity indicates scholarly visibility and growing engagement within the international biomedical research community.[4]

Award Suitability

The research profile aligns with the objectives of the Global Innovation Technologist Awards by demonstrating interdisciplinary scientific investigation, peer-reviewed publication activity, and contributions to translational biomedical research. The combination of clinical expertise and emerging analytical methodologies represents a suitable basis for academic recognition within innovation-focused award programs.[5]

Conclusion

MEHMET KIVRAK’s scholarly activities reflect an emphasis on clinically relevant biomedical research supported by peer-reviewed publications and measurable research metrics. The available evidence highlights sustained contributions to Biology and Life Sciences while promoting interdisciplinary approaches that integrate clinical investigation with innovative analytical techniques.

References

  1. Elsevier. Scopus Author Details: MEHMET KIVRAK, Author ID 57211715569.
    https://www.scopus.com/pages/authors/57211715569
  2. Journal of Clinical Medicine. Lower Urinary Tract System Symptoms and Urinary Incontinence in Hypertensive Disorders of Pregnancy.
    https://doi.org/10.3390/jcm15114162
  3. Journal of Clinical Medicine. Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome.
    https://doi.org/10.3390/jcm15103958
  4. Biology. Unveiling Key Biomarkers of Cardiovascular Risk in Psoriasis Through Explainable Artificial Intelligence.
    https://doi.org/10.3390/biology15070532
  5. Journal of Clinical Medicine. Associations with Methylphenidate Treatment in Emotion Regulation and Skin-Picking Severity in Adolescents with ADHD.
    https://doi.org/10.3390/jcm15062401
  6. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi. Rize Bölgesindeki Gebelerde Emesis Gravidarum Prevalansı.
    https://doi.org/10.17517/ksutfd.1621762

Wei-Li Hsu | Immunology | Women Researcher Award

Prof. Dr. Wei-Li Hsu | Immunology | Women Researcher Award

Professor and Director of Graduate Institute at National Chung Hsing University | Taiwan

Prof. Wei-Li Hsu is a distinguished academic and researcher with extensive expertise in molecular virology and veterinary medicine. Over the years, she has established himself as a leading scholar through his pioneering research, impactful publications, and academic leadership, contributing significantly to both fundamental science and applied biomedical research.

Professional Profile

Scopus

Google Scholar

Educational Background 

She holds a Ph.D. in Molecular Virology from the University of Glasgow, UK, building on a Master’s degree in Veterinary Microbiology and a Doctor of Veterinary Medicine degree from National Chung-Hsing University, Taiwan. This solid academic foundation provided him with interdisciplinary expertise spanning veterinary sciences and advanced virological research.

Professional Experience 

Prof. Hsu has built a long and distinguished career at National Chung-Hsing University (NCHU), Taiwan, where she progressed from Assistant Professor to Associate Professor, Professor, and later Distinguished Professor. She has also served in leadership roles such as Director of the Graduate Institute of Microbiology & Public Health and Associate Dean of the College of Veterinary Medicine. His international career includes postdoctoral research at the University of Alberta, Canada, and the University of Cambridge, UK, along with visiting professorships at the Tokyo University of Agriculture and Technology, Japan, and a visiting scholar appointment at the Icahn School of Medicine at Mount Sinai, USA.

Research Interests 

Her research centers on molecular virology, with a particular focus on influenza viruses, herpesviruses, and the use of viral vectors for therapeutic purposes. His work spans viral pathogenesis, immunogenicity, vaccine development, and the application of attenuated viruses as safe vectors for cancer treatment. She has also contributed to advancing virus-like particle production and the development of novel antiviral strategies.

Awards and Honors 

Prof. Hsu has been repeatedly recognized for his academic excellence. She has held the title of Distinguished Professor at National Chung-Hsing University across multiple terms and received the Outstanding Young Researcher Award from the same institution on several occasions. During his doctoral studies in the UK, she was awarded the prestigious Overseas Research Student Award and postgraduate scholarships from the University of Glasgow.

Research Skills 

She possesses advanced expertise in molecular virology, including viral vector engineering, immunological evaluation of viral antigens, vaccine development, and translational applications of virological research. In addition, his leadership and mentorship skills have enabled him to guide research teams, foster academic collaborations, and contribute to the development of future scientists.

Publication Top Notes

  • Inhibition of enveloped viruses infectivity by curcumin

  • Cited by: 203

  • Year: 2013

  • The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan

  • Cited by: 146

  • Year: 2020

  • Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein

  • Cited by: 113

  • Year: 2008

  • Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury

  • Cited by: 107

  • Year: 2012

  • Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN

  • Cited by: 97

  • Year: 2017

Conclusion 

Prof. Wei-Li Hsu’s career demonstrates a profound commitment to advancing knowledge in molecular virology and veterinary medicine. Through his outstanding research achievements, international collaborations, and leadership in higher education, she has made a lasting impact on science and global health. His work continues to bridge basic research and clinical applications, positioning him as a prominent figure in the field.

 

Didi Chen | Biology | Best Researcher Award

Dr. Didi Chen | Biology | Best Researcher Award

Full-time teacher at Hubei University of Education, China

Dr. Didi Chen is a materials chemist and fluorescence imaging researcher affiliated with the School of Chemistry and Life Sciences, Hubei University of Education. His research primarily focuses on the design and development of fluorescent bioprobes based on Aggregation-Induced Emission (AIE) for biomedical applications such as tumor detection, intraoperative imaging, and biomarker quantification. With multiple publications in high-impact journals and a leading role in national-level research projects, Dr. Chen is contributing to the advancement of bioimaging technologies for real-time diagnostics and cancer surgery guidance.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Materials Science and Engineering
    Beijing Institute of Technology
    September 2013 – June 2017

  • Master’s Degree in Chemistry
    School of Chemistry, Central China Normal University
    September 2009 – June 2012

  • Bachelor’s Degree in Chemistry
    College of Chemistry, Central China Normal University
    September 2005 – June 2009

Professional Experience 💼

  • Faculty Member, School of Chemistry and Life Sciences, Hubei University of Education
    Engaged in teaching and research in materials chemistry and bioimaging.

  • Principal Investigator, National Natural Science Foundation of China (NSFC) Project for Young Scientists (Project No. 22405079)
    2025–2027: Project on real-time navigation of liver cancer surgery using AIE-based fluorescent probes.

  • Active contributor to multidisciplinary research projects in molecular design, bio-detection, and fluorescence-guided surgery.

Research Interests 🔬

  • Aggregation-Induced Emission (AIE) and its application in:

    • Fluorescent probe design

    • Bioimaging and surgical guidance

    • Tumor microenvironment studies

    • Biomolecular sensing (e.g., CO₂, HSA, FIB)

  • Intraoperative imaging techniques for early cancer diagnosis

  • Interaction studies between stromal and tumor cells using AIEgens

Awards and Honors🏆✨

  • Principal Investigator, National Natural Science Foundation of China for Young Scientists (2025–2027)

  • Recognition through peer-reviewed publications in top-tier journals such as Biomaterials, Analytica Chimica Acta, Materials Chemistry Frontiers, Sensors and Actuators B, and Aggregate.

Conclusion🌟

Dr. Didi Chen is an emerging leader in the field of fluorescent bio-probe development for cancer diagnostics and intraoperative applications. His work integrates innovative materials chemistry with real-world clinical challenges, contributing significantly to non-invasive imaging and tumor identification. He has demonstrated capability in acquiring competitive research funding, publishing impactful studies, and advancing knowledge at the interface of chemistry, biology, and medicine.

Given his strong academic background, successful grant leadership, and impactful publication record, Dr. Chen is well-positioned for continued contributions to translational biomedical research and qualifies as a strong candidate for research awards and honors in the fields of chemistry and medical diagnostics.

Publications 📚

1️⃣ 🧪 ND-TPE-COOH: Protein-activated fluorescent diagnostic probes for rapid identification and resection of liver tumors
👩‍🔬 Qu, J., Li, Z., Zhong, H., Mukerabigwi, J.F., Cao, Y.
📘 Sensors and Actuators B: Chemical, 2025
🔬 Focus: Development of a novel fluorescent probe for rapid liver tumor diagnosis and surgical assistance.


2️⃣ 🧬 Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories
👨‍⚕️ Xiao, T., Chen, D., Peng, L., Zhang, J., Li, M.
📕 Review Article, 2025
📈 Citations: 2
💡 Scope: Bridging clinical application and lab development in fluorescence-guided liver cancer surgery.


3️⃣ 💡 The Fluorescent Bioprobe with Aggregation-Induced Emission Features for Monitoring Carbon Dioxide Generation in Single Living Cells
🔬 Chen, D., Wang, H., Dong, L., Liu, P., Zhang, Y., Shi, J., Feng, X., Zhi, J., Tong, B., Dong, Y.
📘 Biomaterials, 2016, 103: 67–74
🧫 Highlights: Real-time CO₂ tracking and early cancer cell detection using AIE-based probes.


4️⃣ 🧪 Two-Step Separation-Free Quantitative Detection of HSA and FIB in Human Plasma using an AIE Probe
🔬 Chen, D., Dong, L., Jiang, S., Li, W., Shi, J., Feng, X., Zhi, J., Tong, B., Li, M., Zheng, Q., Dong, Y.
📙 Sensors and Actuators B: Chemical, 2018, 255: 854–861
💉 Purpose: Efficient biomarker detection without sample separation steps.


5️⃣ 🔬 CO₂-Sensitive AIEgen for Analyzing Tumor-Stroma Interactions in Heterocellular Systems
🔍 Chen, D., Wang, H., Liu, P., Song, L., Shi, J., Tong, B., Dong, Y.
📗 Analytica Chimica Acta, 2018, 1001: 151–157
🧬 Focus: Understanding tumor microenvironment dynamics.


6️⃣ 🧿 A Novel Turn-on Fluorescent Probe for Intraoperative Diagnosis of Hepatocellular Carcinoma
🧪 Chen, D.#, Mao, H.#, Hong, Y., Tan, Y., Zhang, Y., Li, M., Dong, Y.
📕 Materials Chemistry Frontiers, 2020, 4: 2716–2722
🔎 Innovation: Rapid pathological differentiation during surgery using AIEgen derivatives.


7️⃣ 💡 A Simple “Spraying” Fluorescence-Guided Surgery for Liver Tumor Resection
🔬 Chen, D., Xiao, T., Wang, L., Chen, S., Kam, C., Zeng, G., Peng, L., Zhang, J., Li, M., Dong, Y.
📘 Aggregate, 2024, 5: e550
🧠 Impact: Introducing non-invasive, intraoperative tumor visualization via sprayable AIE probes.